New investment from the ADDF’s Diagnostics Accelerator leads efforts to develop standardization materials for leading diagnostic biomarker: New York Saturday, November 16, 2024, ...

Augurex Life Sciences Corp., a leader in autoimmune biomarker-based diagnostics, today announced that it has formed a nonexclusive agreement with Ques ...

A new artificial intelligence tool developed by the Hospital Clínic de Barcelona will facilitate the diagnosis of prostate ...

An ADHD rating scale is an umbrella term for tools used to help patients, families, educators and clinicians assess and ...

Here are the resources you need to avoid firing the parts cannon at a misfiring Toyota engine and/or avoid overpaying a ...

In a breakthrough for tuberculosis (TB) diagnostics, researchers Manaswini Davuluri, Senior Project Manager and Rese ...

The AI diagnostic tool developed at Mass General Brigham indicates that long COVID affects about 23% of people, higher than ...

The test’s ability to distinguish ALS from similar conditions is particularly noteworthy. It could help physicians differentiate between ALS and conditions that mimic its symptoms, such as primary ...

Summary: A new AI tool identified long COVID in 22.8% of patients, a much higher rate than previously diagnosed. By analyzing ...

Investigators at Mass General Brigham have developed an AI-based tool to sift through electronic health records to help clinicians identify cases of long COVID, an often mysterious condition that can ...

Pancreatic cancer (PC) presents substantial diagnostic challenges due to its aggressive nature and lack of early symptoms, ...

These findings demonstrate disparities in precise genetic diagnosis are not due to diagnostic yields ... GeneDx leverages its ...